ANGELA COZART: Open Payments
NPI 1558796235 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,520 in 71 payments from 11 companies in 2025. Trend: 2023 $1,667 · 2024 $1,606 · 2025 $1,520
Food & beverage: $1,520
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $521 |
| Ardelyx, Inc. | 13 | $283 |
| Madrigal Pharmaceuticals | 5 | $238 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $176 |
| Janssen Biotech, Inc. | 6 | $128 |
| Gilead Sciences, Inc. | 2 | $43 |
| Ipsen Biopharmaceuticals, Inc | 2 | $41 |
| Regeneron Healthcare Solutions, Inc. | 1 | $38 |
| Aimmune Therapeutics, Inc. | 1 | $21 |
| Organon LLC | 1 | $18 |
Products named: IBSRELA, REZDIFFRA, RINVOQ, XIFAXAN, SKYRIZI, TREMFYA, CREON, LINZESS.
Industry payments across GA — which companies pay providers there.
